B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MCL1

MOLECULAR TARGET

MCL1 apoptosis regulator, BCL2 family member

UniProt: AAF64255NCBI Gene: 417024 compounds

MCL1 (MCL1 apoptosis regulator, BCL2 family member) is targeted by 24 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MCL1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1DEAD-box RNA Helicases1.614
2Thioctic Acid1.614
3Hexachlorophene1.614
4Thioctic Acid1.614
5Oxytetracycline1.393
6egcg1.102
7Rosmarinic Acid1.102
8paxilline1.102
9caffeic acid0.691
10Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
11Methylene Blue0.691
12Oleic Acid0.691
13Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).0.691
14Aurintricarboxylic Acid0.691
15Camptothecin0.691
16dofetilide0.691
17Domperidone0.691
18Ethionamide0.691
19Metergoline0.691
20Phenoxybenzamine0.691
21Phenylbutazone0.691
22Tetracycline0.691
23Tetraethylammonium0.691
24vinblastine sulfate0.691

About MCL1 as a Drug Target

MCL1 (MCL1 apoptosis regulator, BCL2 family member) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 24 compounds with documented MCL1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MCL1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.